It’s more than what you do: it’s how you do it. Across sectors and borders, in board rooms and courtrooms, we measure our success by yours. And in our interactions, we commit to making your O’Melveny experience as satisfying as the outcomes we help you achieve. Our greatest accomplishment is ensuring that you never have to choose between premier lawyering and exceptional service. So, tell us. What do you want to achieve? Visit us at omm.com.
Pablo Hendler has counseled clients for nearly 25 years in intellectual property matters. Focusing his practice on life science patent litigation, he is well-equipped to counsel clients in pharmaceutical, biotechnology, and medical device litigation. Specifically, Pablo has served as lead counsel, in both the Federal Courts and the Patent Trial and Appeal Board. His extensive litigation experience, and his background as a researcher and inventor, has served him well in counseling clients on how to successfully cross the intersection of FDA and patent law.
Pablo's clients have consistently praised him as an "excellent lawyer" and for his "sterling" work in ANDA litigations. They are comforted by his "seen-and-done-it-all experience" who “blends deep patent law and regulatory knowledge.”
Pablo has written and spoken on a broad range of patent-related topics, particularly in the area of Hatch Waxman litigation.
James Yi Li is a patent litigator at O’Melveny & Myers LLP where he focuses his practice on life sciences matters, including cases brought under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act. James received his law degree from Harvard Law School, where he served as the Submissions Editor for the Harvard Journal of Law & Technology. He has a Masters Degree in Pharmaceutical Engineering and a B.S.E. in Biomedical Engineering, both from the University of Michigan, where he graduated summa cum laude.